GRI Bio Financial Statements From 2010 to 2026
| GRI Etf | USD 0.30 0.01 3.23% |
Market Capitalization 4.3 M | Earnings Share 90.8 |
Check GRI Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GRI Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . GRI financial statements analysis is a perfect complement when working with GRI Bio Valuation or Volatility modules.
This module can also supplement various GRI Bio Technical models . Check out the analysis of GRI Bio Correlation against competitors. GRI Bio ETF Beta Analysis
GRI Bio's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current GRI Bio Beta | -1.44 |
Most of GRI Bio's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GRI Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, GRI Bio has a Beta of -1.441. This is much lower than that of the Biotechnology family and significantly lower than that of the Health Care category. The beta for all United States etfs is notably higher than that of the company.
GRI Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GRI Bio's current stock value. Our valuation model uses many indicators to compare GRI Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GRI Bio competition to find correlations between indicators driving GRI Bio's intrinsic value. More Info.GRI Bio is rated # 2 ETF in price to earning as compared to similar ETFs. It also is rated # 2 ETF in price to book as compared to similar ETFs fabricating about 0.06 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for GRI Bio is roughly 15.43 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GRI Bio's earnings, one of the primary drivers of an investment's value.About GRI Bio Financial Statements
Investors use fundamental indicators, such as GRI Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although GRI Bio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses, of an index called the Cohen Steers Global Realty Majors Index. Cohen Steers is traded on Archipelago Exchange in USA.
Currently Active Assets on Macroaxis
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.